Novel Treatment for Coronary Artery Disease

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

Also called NCT01228214

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
University of Carabobo (from the registry)
Registry
  • NCT NCT01228214
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Venezuela (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01228214. Randomized; double masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Novel Treatment for Coronary Artery Disease
Intervention (Drug)
Placebo
Intervention (Drug)
amiloride
Lead sponsor
University of Carabobo (class: other)
Collaborator
Clinical Research Unit at the Instituto Docente de Urologia (class: not stated)
Collaborator
Northern Metropolitan Hospital (class: not stated)
Collaborator
Venezuelan Foundation of Heart Failure (class: other)

Record details

Record id
cardio:ct-nct01228214
Content hash
620b427b45b2d121e6c106f45546e8da00eba687c40f87aaa62915150d092b0a